JNCE - Jounce Therapeutics, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Jun 2018)Next Qtr. (Sep 2018)Current Year (2018)Next Year (2019)
No. of Analysts5555
Avg. Estimate-0.37-0.38-1.54-1.35
Low Estimate-0.45-0.55-2.1-3.33
High Estimate-0.28-0.28-1.24-0.25
Year Ago EPS-0.11-0.13-0.57-1.54
Revenue EstimateCurrent Qtr. (Jun 2018)Next Qtr. (Sep 2018)Current Year (2018)Next Year (2019)
No. of Analysts5555
Avg. Estimate13.25M13.71M52.64M72.03M
Low Estimate11M11M45M43M
High Estimate14M15M55.2M86.25M
Year Ago Sales20.29M18.08M71.64M52.64M
Sales Growth (year/est)-34.70%-24.20%-26.50%36.80%
Earnings History6/29/20179/29/201712/30/20173/30/2018
EPS Est.-0.15-0.25-0.49-0.31
EPS Actual-0.11-0.13-0.29-0.4
Difference0.040.120.2-0.09
Surprise %26.70%48.00%40.80%-29.00%
EPS TrendCurrent Qtr. (Jun 2018)Next Qtr. (Sep 2018)Current Year (2018)Next Year (2019)
Current Estimate-0.37-0.38-1.54-1.35
7 Days Ago-0.37-0.38-1.54-1.35
30 Days Ago-0.38-0.12-1.32-1.1
60 Days Ago-0.34-0.01-1.04-1.22
90 Days Ago-0.34-0.01-1.04-1.22
EPS RevisionsCurrent Qtr. (Jun 2018)Next Qtr. (Sep 2018)Current Year (2018)Next Year (2019)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 Days2221
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Growth EstimatesJNCEIndustrySectorS&P 500
Current Qtr.-236.40%N/AN/A0.41
Next Qtr.-192.30%N/AN/A0.45
Current Year-170.20%N/AN/A0.21
Next Year12.30%N/AN/A0.11
Next 5 Years (per annum)N/AN/AN/A0.11
Past 5 Years (per annum)N/AN/AN/AN/A